Abstract: A multi-view device for use in conjunction with a display apparatus is provided. The device includes: a lens unit which operates to selectively transmit or block light; a communication unit which communicates with the display apparatus which is displaying a content image; and a controller which receives a beacon signal in synchronization with a display period of the content image from the display apparatus via the communication unit, controls an operation of the lens unit based on the received beacon signal, and changes a reception frequency of the beacon signal in accordance with a running time of the content image displayed on the display apparatus.

Abstract: The present invention relates to a recombinant adenovirus with increased in-vivo safety, tissue specificity, and anticancer activities, and a use thereof. Specifically, the recombinant adenovirus comprising: a promoter of the liver tissue-specific phosphoenolpyruvate carboxykinase (PEPCK) gene; a trans-splicing ribozyme which is operably linked to the promoter and acts on a cancer-specific gene; a therapeutic gene or a reporter gene which is linked to the 3? exon of the ribozyme; and a serotype 35 fiber knob and a serotype 5 shaft, in which the orf4 gene is deleted from adenovirus E1, E3 and E4 orf1, shows remarkable in-vivo safety, high specificity for a target tissue, and remarkable anticancer effects, and thus can be useful for an anticancer drug or a cancer diagnostic agent as a gene delivery vector.

Abstract: Provided is a method of transmitting transport stream packets from a terminal connected to a network including generating a time stamp with reference to time information managed in synchronization with other terminals by a medium access control (MAC) layer in order to control medium use in the network; processing the transport stream packets by using the time stamp; and transmitting the processed transport stream packets.

Abstract: Provided is a method of processing and transmitting transport stream packets and processing the transmitted transport stream packets. A time stamp is generated in a medium access control (MAC) layer based on time information managed by the MAC layer, and a data frame including the transport stream packets is retransmitted based on an algorithm different from that used for a general data frame when a transmission error occurs. Therefore, there is no need to transmit and receive additional synchronization packets in order to precisely transmit the transport stream packets between transmitting and receiving terminals, and it is possible to reduce performance deterioration caused by latency and jitter.

Abstract: Provided are RNA aptamer specifically binding to cancer metastasis-inducing domain of CEA (Carcinoembryonic antigen), a composition for prevention and/or inhibition and/or diagnosis of cancer metastasis containing the same as an active ingredient, and a method of prevention and/or inhibition and/or diagnosis of cancer metastasis using the same.

Abstract: Provided is a substrate treating apparatus. The substrate treating apparatus includes an equipment front end module, a loadlock chamber, a transfer chamber, and a plurality of process chambers. The loadlock chamber includes a cooling unit for cooling a substrate treated in the process chambers, and the cooling unit includes a cooling chamber having an inner space, the cooling chamber having a gas inflow hole in one surface thereof, wherein support pins on which the substrate is placed are disposed around a circumference of the gas injection hole, a cooling gas injection part supplying a cooling gas toward the gas inflow hole, and a gas exhaust part exhausting the cooling gas supplied into the cooling chamber and fumes generated from the substrate to the outside of the cooling chamber.

Abstract: To check security of an Access Point (AP) in a wireless communication system, an operating method of a terminal includes, before completing connection to the AP, receiving a frame that informs the terminal of existence of the AP; extracting security test information from the frame; and testing the security of the AP using the security test information.

Abstract: Provided are RNA aptamer specifically binding to cancer metastasis-inducing domain of CEA (Carcinoembryonic antigen), a composition for prevention and/or inhibition and/or diagnosis of cancer metastasis containing the same as an active ingredient, and a method of prevention and/or inhibition and/or diagnosis of cancer metastasis using the same.

Abstract: A method of synchronizing a display device is presented. The method of synchronizing the display device according to various embodiments includes the steps of: receiving a message from an eyeglass device and confirming the eyeglass device that is to perform synchronization based on the received result; transmitting transmission timing information on a beacon packet having a control signal of the eyeglass device to the eyeglass device; and transmitting the beacon packet to the eyeglass device according to the transmission timing information.

Abstract: Provided are a method and an apparatus for transmitting a packet in a wireless local area network (LAN), the method including determining whether a packet, which does not expire during the current transmission opportunity (TXOP) but will expire before a next TXOP is secured, exists or not based on a time-to-live (TTL) of the packet; if it is determined that the packet does not expire during an expansion of the current TXOP, expanding the current TXOP; and transmitting the packet to a receiving station.

Abstract: A method and apparatus for setting up a wireless ad-hoc network, the method including: interchanging, at a terminal, a terminal identifier and Wi-Fi protected setup (WPS) capability information with another terminal of the wireless ad-hoc network; selecting, at the terminal, a role of the terminal as a registrar or an enrollee based on the interchanged terminal identifier and the interchanged WPS capability information of the wireless ad-hoc network; and optionally registering in the registrar based on the selected role.

Abstract: The present invention relates to a flame-retardant polyolefin resin containing a blend which comprises 0.1-80 wt % of piperazine metal salts or polymers thereof, 10-80.0 wt % of nitrogen-containing synergists or phosphorus/nitrogen retardants, and 1-50 wt % of inorganic compounds, wherein the sum of the components of the blend is 100 wt %.

Abstract: Disclosed herein is a composition for molecular imaging comprising a trans-splicing ribozyme coupled with an imaging reporter gene. The trans-splicing ribozyme targets a specific gene associated with a disease. Also disclosed is a molecular imaging method using the composition.

Abstract: The present invention relates to an aptazyme comprising an aptamer for hepatitis C virus (HCV) RNA-encoding component; a hammerhead ribozyme comprising an antisense sequence to microRNA at the site released by self-cleavage; and a communication module sequence that connects the aptamer and hammerhead ribozyme and triggers a self-cleavage activity of the hammerhead ribozyme upon binding of the aptamer with the HCV RNA-encoding component. The present aptazyme inhibits microRNA activity specifically in HCV proliferating cells and thus a composition of the present invention comprising the aptazyme can be effectively used for treatment of HCV-related diseases.

Abstract: The present invention relates to statistical machine translation, and provides a machine translation device and a machine translation method that acquire a creation probability for a target language from a single corpus while extracting respective conversion probabilities by extracting syntax conversion knowledge and word translation knowledge from a parallel corpus, model a weighted translation model by allowing each of the conversion knowledge and each of the probabilities to learn using a translation model learning device, and generate a target sentence through decoding processes of a syntax converter and a word translator by applying the translation model to a source sentence input in real time, thereby resolving disadvantages of the existing phrase-based SMT and syntax-based SMT and combining advantages thereof.

Abstract: A method of and an apparatus to improve stability and efficiency during data transmission performed over a wireless network includes transmitting a first data frame containing a plurality of data units to a receiving device, receiving from the receiving device a receipt of confirmation for each data unit received by the receiving device, and transmitting a second data frame containing at least one of the plurality of data units that have not been transmitted or received, according to the receipt of confirmation for each data unit received by the receiving device.

Abstract: Provided are a method and an apparatus for transmitting a packet in a wireless local area network (LAN), the method including determining whether a packet, which does not expire during the current transmission opportunity (TXOP) but will expire before a next TXOP is secured, exists or not based on a time-to-live (TTL) of the packet; if it is determined that the packet does not expire during an expansion of the current TXOP, expanding the current TXOP; and transmitting the packet to a receiving station.

Abstract: Provided are a method and apparatus for supporting a multiband wireless fidelity (WiFi). The method for supporting the multiband WIFI includes: assigning a category and a frequency band for traffic, based on one or more characteristics of the traffic; packetizing the traffic in a media access control (MAC) unit corresponding to the assigned frequency band; and transmitting the packetized traffic by using the assigned frequency band in a physical layer (PHY) unit corresponding to the assigned frequency band.

Abstract: Disclosed herein are a recombinant adenovirus comprising tissue-specific promoters and trans-splicing ribozymes targeting tumor-specific genes, and uses thereof. More specifically, disclosed herein are a recombinant adenovirus comprising (1) a tissue-specific promoter, (2) a trans-splicing ribozyme acting on tumor-specific genes operably linked to the promoter, and (3) a therapeutic or reporter gene linked to 3? exon of the ribozyme, an anticancer pharmaceutical composition comprising the same, and a composition for cancer diagnosis comprising the same. The recombinant adenovirus exhibits high specificity and significantly improved therapeutic efficacy to gene targeted tissues. Accordingly, the recombinant adenovirus is useful as a gene delivery vector for anticancer agents or cancer diagnostics.

Abstract: Disclosed is a nuclease-resistant RNA aptamer for inhibiting the replication of HCV replicon. This aptamer is capable of binding specifically to HCV NS5B and inhibiting the proliferation of the HCV replicon, and includes at least one sequence selected from a group consisting of SEQ ID NOS. 1 to 4, in which a fluoro group is substituted for 2?-hydroxy of both U (uracil) and C (cytosine) bases, and SEQ ID NO. 17, in which the fluoro group is substituted for the 2?-hydroxy of both the U (uracil) and the C (cytosine) bases, and which is tagged with a cholesteryl group at a 5? end and with idT at a 3? end. The RNA aptamer is useful in the diagnosis and treatment of HCV infection.